| scholarly article | Q13442814 |
| P50 | author | Bao-Liang Song | Q59691556 |
| P2093 | author name string | Yu Xiang | |
| Jin Zhong | |||
| Jing-Jie Tang | |||
| Wanyin Tao | |||
| Xuezhi Cao | |||
| P2860 | cites work | cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism | Q22008532 |
| Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity | Q24296473 | ||
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity | Q24337582 | ||
| Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms | Q24548483 | ||
| A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
| Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA | Q24634416 | ||
| Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes | Q24673768 | ||
| Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig | Q24683936 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 | ||
| Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins | Q27478188 | ||
| Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress | Q27481013 | ||
| Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor | Q27485871 | ||
| Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production | Q27487550 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Complete replication of hepatitis C virus in cell culture | Q27860934 | ||
| The lipid droplet is an important organelle for hepatitis C virus production | Q28131709 | ||
| Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol | Q28282311 | ||
| Viral reorganization of the secretory pathway generates distinct organelles for RNA replication | Q28283814 | ||
| Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins | Q28646552 | ||
| Genome-scale CRISPR-Cas9 knockout screening in human cells | Q29616044 | ||
| Protein sensors for membrane sterols | Q29617313 | ||
| Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques | Q30054591 | ||
| Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents | Q31045004 | ||
| Current and future therapies for hepatitis C virus infection | Q34036762 | ||
| HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons | Q34247460 | ||
| Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons | Q34378778 | ||
| Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms | Q34616709 | ||
| Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. | Q34698858 | ||
| Listeria monocytogenes infection induces prosurvival metabolic signaling in macrophages | Q34740192 | ||
| Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation | Q34792600 | ||
| Forward genetic screening for regulators involved in cholesterol synthesis using validation-based insertional mutagenesis | Q35451879 | ||
| Hepatitis C virus infection and liver steatosis | Q35593064 | ||
| Systematic identification of type I and type II interferon-induced antiviral factors | Q35837132 | ||
| The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection | Q36402648 | ||
| The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response | Q36567141 | ||
| Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly | Q36913366 | ||
| 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production | Q37377292 | ||
| A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate | Q37547199 | ||
| 25-Hydroxycholesterols in innate and adaptive immunity | Q38260971 | ||
| MDA5 plays a critical role in interferon response during hepatitis C virus infection | Q38933210 | ||
| HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells | Q39036528 | ||
| A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles. | Q39793262 | ||
| Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide | Q39841750 | ||
| Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. | Q39990933 | ||
| Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cells. | Q40588114 | ||
| Hepatitis C virus NS3/4A protease blocks IL-28 production. | Q42981120 | ||
| Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. | Q42981451 | ||
| Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge | Q43048336 | ||
| Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs | Q45081451 | ||
| Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake | Q46884435 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 6805-6816 | |
| P577 | publication date | 2015-04-22 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection | |
| P478 | volume | 89 |
| Q37530422 | 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation |
| Q92904684 | 25-Hydroxycholesterol provides antiviral protection against highly pathogenic porcine reproductive and respiratory syndrome virus in swine |
| Q57476231 | Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol |
| Q63246525 | Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism |
| Q40116058 | Cholesterol 25-Hydroxylase Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication through Enzyme Activity-Dependent and -Independent Mechanisms |
| Q91447831 | Cholesterol 25-Hydroxylase inhibits bovine parainfluenza virus type 3 replication through enzyme activity-dependent and -independent ways |
| Q95836398 | Cholesterol 25-hydroxylase inhibits encephalomyocarditis virus replication through enzyme activity-dependent and independent mechanisms |
| Q43167795 | Cholesterol 25-hydroxylase is an interferon-inducible factor that protects against porcine reproductive and respiratory syndrome virus infection. |
| Q92446302 | Cholesterol-25-hydroxylase Is a Chicken ISG That Restricts ALV-J Infection by Producing 25-hydroxycholesterol |
| Q92197782 | Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis |
| Q63246373 | Fish Cholesterol 25-Hydroxylase Inhibits Virus Replication via Regulating Interferon Immune Response or Affecting Virus Entry |
| Q26779128 | Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection |
| Q39366921 | Immunometabolic Signaling Pathways Contribute to Macrophage and Dendritic Cell Function. |
| Q39076009 | Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection |
| Q40913679 | Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation |
| Q26773261 | Metabolic alterations and hepatitis C: From bench to bedside |
| Q90044646 | Microglial Homeostasis Requires Balanced CSF-1/CSF-2 Receptor Signaling |
| Q56340281 | NEURL3 is an inducible antiviral effector to inhibit HCV assembly by targeting viral E1 glycoprotein |
| Q92152941 | Porcine Reproductive and Respiratory Syndrome Virus E Protein Degrades Porcine Cholesterol 25-Hydroxylase via the Ubiquitin-Proteasome Pathway |
| Q47547628 | Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy |
| Q28084730 | Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network |
| Q57072613 | Sterol Metabolism and Transport in Atherosclerosis and Cancer |
| Q91451009 | The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis |
| Q61820968 | The Oxysterol 25-Hydroxycholesterol Inhibits Replication of Murine Norovirus |
| Q92904071 | The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis |
| Q33911258 | Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. |
Search more.